MODELING PROTEIN SUBSTRATE INTERACTIONS IN THE HEME DOMAIN OF CYTOCHROME P450(BM-3)

被引:108
|
作者
LI, HY
POULOS, TL
机构
[1] UNIV CALIF IRVINE,DEPT MOLEC BIOL & BIOCHEM,IRVINE,CA 92717
[2] UNIV CALIF IRVINE,DEPT PHYSIOL & BIOPHYS,IRVINE,CA 92717
关键词
D O I
10.1107/S0907444994009194
中图分类号
Q5 [生物化学];
学科分类号
071010 ; 081704 ;
摘要
The crystal structure of heme domain of the fatty acid monooxygenase, cytochrome P450(BM-3), consisting of residues 1-455 has been independently solved to R = 0.18 at 2.0 Angstrom. The crystal form used, space group P2(1) with two molecules per asymmetric unit, is isomorphous with that form with residues 1-471 first described by Boddupalli et al. [Boddupalli, Hasemann, Ravinchandran, Lu, Goldsmith, Deisenhofer and Peterson (1992). Proc. Natl Acad. Sci. USA, 89, 5567-5571] and used by Ravichandran, Boddupalli, Hasemann, Peterson and Deisenhofer [(1993). Science, 261, 731-736] to determine the crystal structure. The substrate-access channel consists of a large, hydrophobic cleft that appears to be the most likely route taken by fatty acid substrates. Attempts to soak crystals in mother liquor containing a variety of fatty acid substrates yielded featureless difference Fouriers even though fatty acid substrates are known to bind with dissociation constants in the mu M range. Modeling substrate-enzyme interactions reveals few contacts between the enzyme and substrate. More detailed modeling was carried out by subjecting both molecules in the asymmetric unit to extensive energy minimization. These studies reveal that the heme-domain active-site cleft can undergo a large conformational change that closes the access channel thereby providing enhanced protein-substrate interactions. These conformational changes are prevented from occuring by intermolecular contacts in the crystal lattice which lock the protein in the 'open' conformation.
引用
收藏
页码:21 / 32
页数:12
相关论文
共 50 条
  • [1] THE INTERACTION OF CYTOCHROME-C AND THE HEME DOMAIN OF CYTOCHROME P-450(BM-3) WITH THE REDUCTASE DOMAIN OF CYTOCHROME P-450(BM-3)
    KLEIN, ML
    FULCO, AJ
    BIOCHIMICA ET BIOPHYSICA ACTA-GENERAL SUBJECTS, 1994, 1201 (02): : 245 - 250
  • [2] P450 BM-3: Substrate binding and protein/protein interaction
    Peterson, JA
    FASEB JOURNAL, 1997, 11 (09): : A773 - A773
  • [3] ROLE OF THE LINKER REGION CONNECTING THE REDUCTASE AND HEME DOMAINS IN CYTOCHROME P450(BM-3)
    GOVINDARAJ, S
    POULOS, TL
    BIOCHEMISTRY, 1995, 34 (35) : 11221 - 11226
  • [4] Biotransformation of β-ionone by engineered cytochrome P450 BM-3
    Vlada B. Urlacher
    Akhmadjan Makhsumkhanov
    Rolf D. Schmid
    Applied Microbiology and Biotechnology, 2006, 70 : 53 - 59
  • [5] Global incorporation of norleucine in place of methionine in cytochrome P450 BM-3 heme domain increases peroxygenase activity
    Cirino, PC
    Tang, Y
    Takahashi, K
    Tirrell, DA
    Arnold, FH
    BIOTECHNOLOGY AND BIOENGINEERING, 2003, 83 (06) : 729 - 734
  • [6] Novel substrates for mechanistic studies with cytochrome P450 BM-3
    Coon, MJ
    McGinnity, DF
    Vaz, ADN
    Liu, HM
    Mullin, DA
    Sato, H
    Shimizu, T
    FASEB JOURNAL, 1997, 11 (09): : A809 - A809
  • [7] Directed evolution of cytochrome P450 BM-3 by saturation mutagenesis
    Li, Hong-Mei
    Mei, Le-He
    Urlacher, V.B.
    Schmid, R.D.
    Zhejiang Daxue Xuebao (Gongxue Ban)/Journal of Zhejiang University (Engineering Science), 2007, 41 (07): : 1214 - 1218
  • [8] CYTOCHROME-C DOES NOT INHIBIT MYRISTATE HYDROXYLATION BY P450(BM-3) - MYRISTATE DOES NOT INHIBIT CYTOCHROME-C REDUCTION BY P450(BM-3)
    KLEIN, ML
    FULCO, AJ
    FASEB JOURNAL, 1993, 7 (07): : A1203 - A1203
  • [9] Decreased substrate affinity upon alteration of the substrate-docking region in cytochrome P450(BM-3)
    Maves, SA
    Yeom, H
    McLean, MA
    Sligar, SG
    FEBS LETTERS, 1997, 414 (02): : 213 - 218
  • [10] Catalytically self-sufficient P450 CYP102 (cytochrome P450 BM-3):: Resonance Raman spectral characterization of the heme domain and of the holoenzyme
    Hudeèek, J
    Baumruk, V
    Anzenbacher, P
    Munro, AW
    BIOCHEMICAL AND BIOPHYSICAL RESEARCH COMMUNICATIONS, 1998, 243 (03) : 811 - 815